| scholarly article | Q13442814 |
| P50 | author | Lydia E. Kavraki | Q11749 |
| Didier Devaurs | Q56805024 | ||
| Dinler A Antunes | Q57118689 | ||
| P2860 | cites work | Systematic and efficient side chain optimization for molecular docking using a cheapest-path procedure | Q46572664 |
| Molecular docking to ensembles of protein structures | Q46668232 | ||
| Flexible protein-flexible ligand docking with disrupted velocity simulated annealing. | Q46934304 | ||
| Ensemble docking into multiple crystallographically derived protein structures: an evaluation based on the statistical analysis of enrichments | Q47618164 | ||
| Protein-ligand docking accounting for receptor side chain and global flexibility in normal modes: evaluation on kinase inhibitor cross docking | Q47669698 | ||
| Docking ligands into flexible and solvated macromolecules. 3. Impact of input ligand conformation, protein flexibility, and water molecules on the accuracy of docking programs | Q47948640 | ||
| Toward on-the-fly quantum mechanical/molecular mechanical (QM/MM) docking: development and benchmark of a scoring function. | Q51027478 | ||
| Modeling loop backbone flexibility in receptor-ligand docking simulations. | Q51334109 | ||
| Application of Drug-Perturbed Essential Dynamics/Molecular Dynamics (ED/MD) to Virtual Screening and Rational Drug Design. | Q51346676 | ||
| Flexible protein docking refinement using pose-dependent normal mode analysis. | Q51366191 | ||
| Efficient inclusion of receptor flexibility in grid-based protein-ligand docking. | Q51532081 | ||
| Application of a Theory of Enzyme Specificity to Protein Synthesis | Q24620284 | ||
| Protein flexibility in docking and surface mapping | Q26864013 | ||
| Exploring the role of receptor flexibility in structure-based drug discovery | Q27001129 | ||
| Novel allosteric sites on Ras for lead generation | Q27317333 | ||
| Electrostatic contributions drive the interaction betweenStaphylococcus aureusprotein Efb-C and its complement target C3d | Q27651460 | ||
| UCSF Chimera--a visualization system for exploratory research and analysis | Q27860666 | ||
| Conformational transitions upon ligand binding: holo-structure prediction from apo conformations | Q28472382 | ||
| Systematic exploitation of multiple receptor conformations for virtual ligand screening | Q28478200 | ||
| PaFlexPepDock: parallel ab-initio docking of peptides onto their receptors with full flexibility based on Rosetta | Q28538537 | ||
| ICM?A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation | Q29010774 | ||
| AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility | Q29547658 | ||
| Macromolecular modeling with rosetta | Q29615856 | ||
| Developing a dynamic pharmacophore model for HIV-1 integrase. | Q30326870 | ||
| FlexE: efficient molecular docking considering protein structure variations. | Q30328164 | ||
| Novel procedure for modeling ligand/receptor induced fit effects. | Q30352584 | ||
| Methods for docking small molecules to macromolecules: a user's perspective. 2. Applications. | Q30352877 | ||
| Effective handling of induced-fit motion in flexible docking. | Q30353351 | ||
| Ensemble docking of multiple protein structures: considering protein structural variations in molecular docking. | Q30357936 | ||
| Exploring experimental sources of multiple protein conformations in structure-based drug design. | Q30362194 | ||
| Potential and limitations of ensemble docking | Q30415116 | ||
| Tackling the challenges posed by target flexibility in drug design | Q30419540 | ||
| CABS-fold: Server for the de novo and consensus-based prediction of protein structure | Q30431648 | ||
| Benchmark data sets for structure-based computational target prediction | Q30840167 | ||
| Identification of a minimal subset of receptor conformations for improved multiple conformation docking and two-step scoring | Q33197071 | ||
| A flexible approach to induced fit docking | Q33306730 | ||
| Chemical space sampling by different scoring functions and crystal structures. | Q51703673 | ||
| DynaDock: A new molecular dynamics-based algorithm for protein-peptide docking including receptor flexibility. | Q51766267 | ||
| RosettaLigand docking with full ligand and receptor flexibility. | Q51861937 | ||
| Ensemble Docking from Homology Models. | Q51902480 | ||
| Docking ligands into flexible and solvated macromolecules. 1. Development and validation of FITTED 1.0. | Q51922137 | ||
| ROSETTALIGAND: protein-small molecule docking with full side-chain flexibility. | Q51933455 | ||
| Fully flexible low-mode docking: application to induced fit in HIV integrase. | Q52050278 | ||
| Side-chain flexibility in proteins upon ligand binding. | Q52080522 | ||
| Docking of flexible ligands to flexible receptors in solution by molecular dynamics simulation. | Q52216410 | ||
| Molecular dynamics simulation of the docking of substrates to proteins. | Q52375019 | ||
| Ligand docking to proteins with discrete side-chain flexibility. | Q52383197 | ||
| Coarse-Grained Modeling of Peptide Docking Associated with Large Conformation Transitions of the Binding Protein: Troponin I Fragment-Troponin C System. | Q53641996 | ||
| Selective flexibility of side-chain residues improves VEGFR-2 docking score using AutoDock Vina. | Q54541635 | ||
| How to choose relevant multiple receptor conformations for virtual screening: a test case of Cdk2 and normal mode analysis | Q56984187 | ||
| Complementarity of Structure Ensembles in Protein-Protein Binding | Q57815055 | ||
| Receptor flexibility in small-molecule docking calculations | Q57975284 | ||
| Modeling Structures and Motions of Loops in Protein Molecules | Q58449165 | ||
| Improved docking, screening and selectivity prediction for small molecule nuclear receptor modulators using conformational ensembles | Q33573726 | ||
| Rapid flexible docking using a stochastic rotamer library of ligands | Q33659311 | ||
| Multi-scale characterization of the energy landscape of proteins with application to the C3D/Efb-C complex | Q33684624 | ||
| From induced fit to conformational selection: a continuum of binding mechanism controlled by the timescale of conformational transitions | Q33767651 | ||
| Mining flexible-receptor docking experiments to select promising protein receptor snapshots | Q33787280 | ||
| Rosetta FlexPepDock ab-initio: simultaneous folding, docking and refinement of peptides onto their receptors | Q33900072 | ||
| Utilizing experimental data for reducing ensemble size in flexible-protein docking | Q34092829 | ||
| On the applicability of elastic network normal modes in small-molecule docking | Q34154973 | ||
| Testing a flexible-receptor docking algorithm in a model binding site | Q34309041 | ||
| Equilibrium fluctuations of a single folded protein reveal a multitude of potential cryptic allosteric sites | Q34323850 | ||
| ALiBERO: evolving a team of complementary pocket conformations rather than a single leader | Q34402706 | ||
| Protein folding: binding of conformationally fluctuating building blocks via population selection | Q34449519 | ||
| Induced fit, conformational selection and independent dynamic segments: an extended view of binding events | Q34479883 | ||
| Docking-based virtual screening for ligands of G protein-coupled receptors: not only crystal structures but also in silico models. | Q34561020 | ||
| Prediction of the binding site of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine in acetylcholinesterase by docking studies with the SYSDOC program | Q34662381 | ||
| DOLINA--docking based on a local induced-fit algorithm: application toward small-molecule binding to nuclear receptors. | Q34750689 | ||
| SIMS: a hybrid method for rapid conformational analysis. | Q34918623 | ||
| Methods for docking small molecules to macromolecules: a user's perspective. 1. The theory. | Q34943169 | ||
| Predictive power of molecular dynamics receptor structures in virtual screening | Q35073109 | ||
| DINC: a new AutoDock-based protocol for docking large ligands. | Q35101950 | ||
| Conformational flexibility models for the receptor in structure based drug design. | Q35181130 | ||
| Challenges, applications, and recent advances of protein-ligand docking in structure-based drug design. | Q35206344 | ||
| Efficient incorporation of protein flexibility and dynamics into molecular docking simulations | Q35211087 | ||
| Significant enhancement of docking sensitivity using implicit ligand sampling | Q35211103 | ||
| Discovery of novel checkpoint kinase 1 inhibitors by virtual screening based on multiple crystal structures | Q35630615 | ||
| GalaxyPepDock: a protein-peptide docking tool based on interaction similarity and energy optimization | Q35810303 | ||
| Efficient molecular docking of NMR structures: application to HIV-1 protease | Q36420334 | ||
| Accounting for receptor flexibility and enhanced sampling methods in computer-aided drug design | Q36520871 | ||
| An improved relaxed complex scheme for receptor flexibility in computer-aided drug design | Q36838120 | ||
| Computational models of protein kinematics and dynamics: beyond simulation | Q36900683 | ||
| Automated docking with protein flexibility in the design of femtomolar "click chemistry" inhibitors of acetylcholinesterase | Q36974755 | ||
| Managing protein flexibility in docking and its applications | Q37382489 | ||
| An Evaluation of Explicit Receptor Flexibility in Molecular Docking Using Molecular Dynamics and Torsion Angle Molecular Dynamics | Q37409322 | ||
| Conformational selection and induced fit mechanism underlie specificity in noncovalent interactions with ubiquitin | Q37428879 | ||
| Allostery and population shift in drug discovery | Q37795355 | ||
| Recent work in the development and application of protein-peptide docking | Q38037195 | ||
| Incorporating protein flexibility into docking and structure-based drug design. | Q38089793 | ||
| Latest developments in molecular docking: 2010-2011 in review | Q38092807 | ||
| Protein-ligand docking in the new millennium--a retrospective of 10 years in the field | Q38093314 | ||
| Automated docking for novel drug discovery | Q38103932 | ||
| One hundred thousand mouse clicks down the road: selected online resources supporting drug discovery collected over a decade | Q38119805 | ||
| Multiscale characterization of protein conformational ensembles | Q38272896 | ||
| Conformational selection or induced fit? 50 years of debate resolved | Q38363774 | ||
| Improvements, trends, and new ideas in molecular docking: 2012-2013 in review. | Q38390892 | ||
| Rosetta Ligand docking with flexible XML protocols | Q38425928 | ||
| Protein Flexibility in Drug Discovery: From Theory to Computation | Q38428430 | ||
| Receptor-ligand molecular docking | Q38783140 | ||
| GalaxyDock: protein-ligand docking with flexible protein side-chains | Q39510852 | ||
| Consistent improvement of cross-docking results using binding site ensembles generated with elastic network normal modes | Q41382543 | ||
| Soft docking and multiple receptor conformations in virtual screening | Q41968000 | ||
| Hybrid Steered Molecular Dynamics-Docking: An Efficient Solution to the Problem of Ranking Inhibitor Affinities Against a Flexible Drug Target | Q41998223 | ||
| Recipes for the selection of experimental protein conformations for virtual screening | Q42081112 | ||
| Expanding the conformational selection paradigm in protein-ligand docking | Q42629379 | ||
| o-Alkylselenenylated benzoic acid accesses several sites in serum albumin according to fluorescence studies, Raman spectroscopy and theoretical simulations. | Q42715923 | ||
| Synergistic effects in the designs of neuraminidase ligands: analysis from docking and molecular dynamics studies | Q42910761 | ||
| Studies of benzothiadiazine derivatives as hepatitis C virus NS5B polymerase inhibitors using 3D-QSAR, molecular docking and molecular dynamics | Q42998095 | ||
| Simulating ligand-induced conformational changes in proteins using a mechanical disassembly method | Q43043630 | ||
| Homology modeling and docking evaluation of aminergic G protein-coupled receptors | Q43148221 | ||
| Four-dimensional docking: a fast and accurate account of discrete receptor flexibility in ligand docking | Q43153980 | ||
| In pursuit of virtual lead optimization: pruning ensembles of receptor structures for increased efficiency and accuracy during docking | Q43170586 | ||
| Predicting structural effects in HIV-1 protease mutant complexes with flexible ligand docking and protein side-chain optimization | Q43686780 | ||
| Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation | Q43987901 | ||
| Computational drug design accommodating receptor flexibility: the relaxed complex scheme | Q43992973 | ||
| A new method for induced fit docking (GENIUS) and its application to virtual screening of novel HCV NS3-4A protease inhibitors | Q44012860 | ||
| Pharmacophore-based molecular docking to account for ligand flexibility | Q44379444 | ||
| The ensemble performance index: an improved measure for assessing ensemble pose prediction performance. | Q44636889 | ||
| "Soft docking": matching of molecular surface cubes | Q44675898 | ||
| Rapid protein-ligand docking using soft modes from molecular dynamics simulations to account for protein deformability: binding of FK506 to FKBP. | Q44784463 | ||
| Protein flexibility in ligand docking and virtual screening to protein kinases. | Q44786754 | ||
| Computational modeling on the recognition of the HRE motif by HIF-1: molecular docking and molecular dynamics studies | Q46122781 | ||
| Representing receptor flexibility in ligand docking through relevant normal modes. | Q46211444 | ||
| Unveiling the full potential of flexible receptor docking using multiple crystallographic structures | Q46563192 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | protein design | Q410814 |
| P304 | page(s) | 1301-1313 | |
| P577 | publication date | 2015-09-28 | |
| P1433 | published in | Expert Opinion on Drug Discovery | Q5421204 |
| P1476 | title | Understanding the challenges of protein flexibility in drug design | |
| P478 | volume | 10 |
| Q38610941 | A cross docking pipeline for improving pose prediction and virtual screening performance. |
| Q41500458 | A protocol for CABS-dock protein-peptide docking driven by side-chain contact information. |
| Q55432485 | A selective method for optimizing ensemble docking-based experiments on an InhA Fully-Flexible receptor model. |
| Q64072346 | APE-Gen: A Fast Method for Generating Ensembles of Bound Peptide-MHC Conformations |
| Q91143383 | Accelerated Structural Prediction of Flexible Protein-Ligand Complexes: The SLICE Method |
| Q92192949 | Antimicrobial Peptide Designing and Optimization Employing Large-Scale Flexibility Analysis of Protein-Peptide Fragments |
| Q39359047 | Characterization and Prediction of Protein Flexibility Based on Structural Alphabets. |
| Q92290431 | Combined Ensemble Docking and Machine Learning in Identification of Therapeutic Agents with Potential Inhibitory Effect on Human CES1 |
| Q38890648 | Computational functional group mapping for drug discovery |
| Q47577212 | DINC 2.0: A New Protein-Peptide Docking Webserver Using an Incremental Approach. |
| Q57492456 | Empirical Scoring Functions for Structure-Based Virtual Screening: Applications, Critical Aspects, and Challenges |
| Q41846781 | Evaluation of the novel algorithm of flexible ligand docking with moveable target-protein atoms |
| Q52358306 | General Prediction of Peptide-MHC Binding Modes Using Incremental Docking: A Proof of Concept. |
| Q89884541 | Immune Responses Induced by pVAX/TgERK7 against Toxoplasma gondii Infection in BALB/c Mice |
| Q50886907 | Insights into the RNA binding mechanism of human L1-ORF1p: a molecular dynamics study. |
| Q64098229 | Middle-way flexible docking: Pose prediction using mixed-resolution Monte Carlo in estrogen receptor α |
| Q41500445 | Modeling EphB4-EphrinB2 protein-protein interaction using flexible docking of a short linear motif |
| Q58607124 | Modeling of Protein Structural Flexibility and Large-Scale Dynamics: Coarse-Grained Simulations and Elastic Network Models |
| Q47400742 | Molecular dynamics simulations and novel drug discovery |
| Q46066890 | POVME 3.0: Software for Mapping Binding Pocket Flexibility. |
| Q91682177 | Protein-peptide docking using CABS-dock and contact information |
| Q37460191 | Protein-peptide molecular docking with large-scale conformational changes: the p53-MDM2 interaction. |
| Q64967085 | Structure-Based Drug Design for Cytochrome P450 Family 1 Inhibitors. |
| Q92635049 | Structure-Based Virtual Screening, Molecular Dynamics and Binding Free Energy Calculations of Hit Candidates as ALK-5 Inhibitors |
| Q90735752 | Structure-based Methods for Binding Mode and Binding Affinity Prediction for Peptide-MHC Complexes |
| Q47690085 | Tailored Approaches in Drug Development and Diagnostics: From Molecular Design to Biological Model Systems |
| Q33867041 | The impact of the butterfly effect on human parainfluenza virus haemagglutinin-neuraminidase inhibitor design |
| Q93128454 | Using parallelized incremental meta-docking can solve the conformational sampling issue when docking large ligands to proteins |
Search more.